Skip to main content
. Author manuscript; available in PMC: 2013 Nov 28.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Jul 3;85(3):10.1016/j.ijrobp.2012.05.033. doi: 10.1016/j.ijrobp.2012.05.033

Table 4.

Acute and late toxicities in patients treated with HDR interstitial brachytherapy

Grade 1
Grade 2
Grade 3
Grade 4
Toxicity n % n % n % n %
Acute toxicity
 Genitourinary 48 41 3 2.6 0 0 0 0
 Gastrointestinal 40 34 9 7.8 1 0.9 0 0
Late toxicity
 Genitourinary 7 6 4 3.4 5 4.3 0 0
 Gastrointestinal 8 6.9 9 7.8 9 7.8 0 0
 Vaginal 0 0 1 0.9 1 0.9 0 0
Fistula formation
 Vesicovaginal 0 0 2 1.7 2 1.7 0 0
 Rectovaginal 0 0 0 0 1 0.9 1 0.9

Abbreviation: HDR = high-dose-rate.